ImmunityBio, Inc.
IBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$67 | -$93 | -$130 | -$59 |
| Dep. & Amort. | $0 | $4 | $4 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $10 | $10 | $9 |
| Change in WC | $0 | -$6 | -$22 | -$11 |
| Other Non-Cash | -$2 | $5 | $52 | -$28 |
| Operating Cash Flow | -$69 | -$80 | -$86 | -$85 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$15 | -$0 | -$6 |
| Inv. Sales/Matur. | $0 | $0 | $5 | $18 |
| Other Inv. Act. | -$181 | $0 | $0 | $0 |
| Investing Cash Flow | -$181 | -$16 | $4 | $10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | $0 | $0 |
| Stock Issued | $0 | $173 | $0 | $108 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $174 | -$0 | -$1 | -$1 |
| Financing Cash Flow | $174 | $173 | -$1 | $107 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$77 | $77 | -$83 | $32 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $138 | $61 | $144 | $112 |
| End Cash | $61 | $138 | $61 | $144 |
| Free Cash Flow | -$69 | -$81 | -$87 | -$87 |